The clinical outcome and safety of generic DAA treatment for HCV infection in Vietnam in 2016

Vu H. T. T.; Ishizaki A.; Nguyen Q. T.; Nguyen H. N.; Le H. T.; Nguyen T. V.; Nguyen K. V.; Ichimura H.

首页> 外文期刊>Journal of viral hepatitis. >The clinical outcome and safety of generic DAA treatment for HCV infection in Vietnam in 2016

【24h】

The clinical outcome and safety of generic DAA treatment for HCV infection in Vietnam in 2016

机译：越南越南普通型DAA治疗的临床结果与安全

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of viral hepatitis.》 |2018年第s2期|共2页
作者
Vu H. T. T.; Ishizaki A.; Nguyen Q. T.; Nguyen H. N.; Le H. T.; Nguyen T. V.; Nguyen K. V.; Ichimura H.;
展开▼
作者单位

Natl Hosp Trop Dis Hanoi Vietnam;

Kanazawa Univ Viral Infect &

Int Hlth Kanazawa Ishikawa Japan;

Natl Hosp Trop Dis Hanoi Vietnam;

Natl Hosp Trop Dis Hanoi Vietnam;

Natl Hosp Trop Dis Hanoi Vietnam;

Natl Hosp Trop Dis Hanoi Vietnam;

Natl Hosp Trop Dis Hanoi Vietnam;

Kanazawa Univ Viral Infect &

Int Hlth Kanazawa Ishikawa Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical outcomes of patients with chronic hepatitis C after generic direct-acting antiviral treatments in Vietnam: A retrospective analysis [J] . Huong TT Vu, Azumi Ishizaki, Quynh T Nguyen, 亚太热带医药杂志（英文版） . 2020,第011期
2. Efficacy and Safety of Ombitasvir plus Paritaprevir,Ritonavir and Ribavirin in Non-cirrhotic Treatment-naive and Treatment-experienced Egyptians with Chronic HCV Genotype-4 Infection [J] . Manar Ahmed, Azza E.Mansey, Engy A.Wahsh, 当代医学科学(英文) . 2021,第003期
3. Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients： one-year clinical and eight-month angiographic outcomes from the FIREMAN registry [J] . LI Yan, LI Cheng-xiang, WANG Hai-chang, 中华医学杂志：英文版 . 2011,第006期
4. Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes from the FIREMAN registry [J] . LI Yan, SHEN Wen-kuang, JIANG Hong, 中华医学杂志（英文版） . 2011,第006期
5. P1‐076: The clinical outcome and safety of generic DAA treatment for HCV infection in Vietnam in 2016 [J] . Journal of viral hepatitis. . 2018,第S1期

机译：P1-076：2016年越南HCV感染通用DAA治疗的临床结果和安全性
6. Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study [J] . Welzel Tania M., Nelson David R., Morelli Giuseppe, Gut: Journal of the British Society of Gastroenterology . 2017,第10期

机译：Sofosbuvir Plus利巴韦林治疗HCV基因型2感染的有效性和安全性：现实世界的结果，临床实践HCV-靶研究
7. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort [J] . Luis Calleja Jose, Crespo Javier, Rincon Diego, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2017,第6期

机译：HCV基因型1感染直接作用抗病毒治疗的有效性，安全性和临床结果1感染：西班牙现实世界队列的结果
8. HCV-related Factors but not HIV-Related Factors at Baseline Predict the Response to Treatment With Peginterferon alfa-2a (40KD) (PEGASYS) Plus Ribavirin (COPEGUS) in Patients With HCV/HIV Co-infection: Predictor Analysis From the APRICOT Study [C] . D. Cooper, F.J. Torriani, M. Rodriguez Torres International AIDS Conference . 2004

机译：HCV相关因素但基线上没有艾滋病毒相关因素预测与HCV / HIV共感染患者的Peginterferon Alfa-2a（40kd）（Pegasys）（Pegasys）加利巴韦林（Copegus）对治疗的反应：来自杏研究的预测因素分析
9. The impact of pharmacodynamic parameters on prediction of clinical outcome in HIV-1 infected patients and HCV patients with HIV co-infection. [D] . Kim, Tae Eun. 2012

机译：药效学参数对HIV-1感染的患者和HCV合并感染的HCV患者的临床结局预测的影响。
10. Original article: Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world clinical practice HCV-TARGET study [O] . Tania M Welzel, David R Nelson, Giuseppe Morelli, -1

机译：原始文章：索非布韦联合利巴韦林治疗HCV基因型2型感染的有效性和安全性：实际临床研究HCV-TARGET研究的结果
11. Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis [O] . Chengjun Yu, Lian Kang, Jiadong Chen, 2020

机译：评估临床实践中人冠状病毒（HCOVS）感染的I型干扰素的安全性，疗效，耐受性和治疗相关结果：更新的关键系统审查和META分析
12. Compounds, Methods and Compositions Useful for the Treatment of Bovine Viral Diarrhea Virus (BVDV) Infection and Hepatitis C Virus (HCV) Infection. [R] . Dykstra, C. C., Givens, M. D., Stringfellow, D. A., 2005

机译：可用于治疗牛病毒性腹泻病毒（BVDV）感染和丙型肝炎病毒（HCV）感染的化合物，方法和组合物。

The clinical outcome and safety of generic DAA treatment for HCV infection in Vietnam in 2016

著录项

相似文献

相关主题

期刊订阅